Carbonyl reductase 1 (CBR1) belongs to the short dehydrogenase (SDR) family, which could promote AML cell resistance to daunorubicin and be a risk gene in AML patients [23]. This evidence concerns the gene CBR1 and acute myeloid leukemia.